Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Regorafenib

  • Open Access
    The Effect of Statin Usage on Survival in Metastatic Colorectal Cancer Patients Receiving Regorafenib
    EFE CEM ERDAT, ENGIN EREN KAVAK, MERIH YALCINER and GUNGOR UTKAN
    In Vivo November 2024, 38 (6) 2921-2927; DOI: https://doi.org/10.21873/invivo.13774
  • You have access
    Induction of Apoptosis and Inhibition of EGFR/NF-κB Signaling Are Associated With Regorafenib-sensitized Non-small Cell Lung Cancer to Cisplatin
    JENG-YUAN WU, YUEH-SHAN WENG, YI-CHOU CHIOU, FEI-TING HSU and I-TSANG CHIANG
    In Vivo September 2021, 35 (5) 2569-2576; DOI: https://doi.org/10.21873/invivo.12539
In Vivo

© 2026 In Vivo

Powered by HighWire